Danxia Zhu

3.2k total citations
72 papers, 2.5k citations indexed

About

Danxia Zhu is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Danxia Zhu has authored 72 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 34 papers in Cancer Research and 23 papers in Genetics. Recurrent topics in Danxia Zhu's work include MicroRNA in disease regulation (24 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Lymphoma Diagnosis and Treatment (19 papers). Danxia Zhu is often cited by papers focused on MicroRNA in disease regulation (24 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Lymphoma Diagnosis and Treatment (19 papers). Danxia Zhu collaborates with scholars based in China and United States. Danxia Zhu's co-authors include Wei Zhu, Tongshan Wang, Ping Liu, Jingting Jiang, Xin Zhou, Yiting Geng, Yongqian Shu, Lei Fan, Kourong Miao and Wei Xu and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Danxia Zhu

70 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danxia Zhu China 25 1.6k 1.6k 522 286 260 72 2.5k
Tomoko Iehara Japan 24 1.5k 0.9× 1.1k 0.7× 726 1.4× 237 0.8× 186 0.7× 117 3.2k
Katja Gwin United States 18 1.3k 0.8× 1.3k 0.8× 659 1.3× 286 1.0× 162 0.6× 48 2.6k
Navin Pinto United States 18 707 0.4× 546 0.3× 694 1.3× 186 0.7× 118 0.5× 61 1.9k
Jason Kaplan United States 19 774 0.5× 399 0.2× 612 1.2× 215 0.8× 286 1.1× 61 1.7k
Xiaochun Fei China 27 634 0.4× 764 0.5× 874 1.7× 292 1.0× 407 1.6× 90 2.2k
Valentina Fonsato Italy 22 1.4k 0.9× 813 0.5× 214 0.4× 231 0.8× 82 0.3× 29 2.1k
Christoph Thorns Germany 25 661 0.4× 454 0.3× 698 1.3× 273 1.0× 716 2.8× 83 1.8k
Yin‐Hsun Feng Taiwan 20 732 0.4× 476 0.3× 475 0.9× 141 0.5× 127 0.5× 69 1.5k
Laura Boldrini Italy 27 1.2k 0.7× 652 0.4× 916 1.8× 167 0.6× 126 0.5× 98 2.5k
Deolinda Pereira Portugal 26 937 0.6× 514 0.3× 1.3k 2.5× 274 1.0× 446 1.7× 86 2.8k

Countries citing papers authored by Danxia Zhu

Since Specialization
Citations

This map shows the geographic impact of Danxia Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danxia Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danxia Zhu more than expected).

Fields of papers citing papers by Danxia Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danxia Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danxia Zhu. The network helps show where Danxia Zhu may publish in the future.

Co-authorship network of co-authors of Danxia Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Danxia Zhu. A scholar is included among the top collaborators of Danxia Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danxia Zhu. Danxia Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xue & Danxia Zhu. (2024). Role of disulfide death in cancer (Review). Oncology Letters. 29(1). 55–55. 1 indexed citations
2.
Cui, Mengying, et al.. (2021). Aberrant lipid metabolism reprogramming and immune microenvironment for gastric cancer: a literature review. Translational Cancer Research. 10(8). 3829–3842. 16 indexed citations
3.
Zhang, Shiyu, Cheng Liu, Xuan Zou, et al.. (2021). MicroRNA panel in serum reveals novel diagnostic biomarkers for prostate cancer. PeerJ. 9. e11441–e11441. 17 indexed citations
4.
Li, Xiaodong, et al.. (2020). PD-L1 for gallbladder cancer: case report. Translational Cancer Research. 9(5). 3742–3749. 1 indexed citations
5.
Yin, Yin, Shan Xia, Xin Zhou, et al.. (2019). The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer. The American Journal of the Medical Sciences. 358(4). 256–267. 41 indexed citations
6.
Zhang, Yan, et al.. (2018). MSH homeobox 1 polymorphisms and the risk of non‐syndromic orofacial clefts: a meta‐analysis. European Journal Of Oral Sciences. 126(3). 180–185. 12 indexed citations
7.
Geng, Yiting, Danxia Zhu, Chen Wu, et al.. (2018). A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. International Immunopharmacology. 65. 503–510. 127 indexed citations
8.
Yan, Haijiao, Qing Li, Jun Wu, et al.. (2017). MiR-629 promotes human pancreatic cancer progression by targeting FOXO3. Cell Death and Disease. 8(10). e3154–e3154. 43 indexed citations
9.
Huang, Zebo, Danxia Zhu, Lirong Wu, et al.. (2016). Six Serum-Based miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer. Cancer Epidemiology Biomarkers & Prevention. 26(2). 188–196. 114 indexed citations
10.
Geng, Yiting, Yingjie Shao, Danxia Zhu, et al.. (2016). Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis. Scientific Reports. 6(1). 39482–39482. 187 indexed citations
11.
Zhu, Danxia, Cheng Fang, Mei Ji, et al.. (2015). Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis.. PubMed. 8(9). 15340–50. 5 indexed citations
12.
Wang, Yinhua, Zhi‐Jian Zou, Lina Zhang, et al.. (2012). Quantification of ZAP-70 mRNA by real-time PCR is a prognostic factor in chronic lymphocytic leukemia. Journal of Cancer Research and Clinical Oncology. 138(6). 1011–1017. 8 indexed citations
13.
Zhu, Danxia, Wei Zhu, Cheng Fang, et al.. (2012). miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. Carcinogenesis. 33(7). 1294–1301. 162 indexed citations
14.
Zhu, Danxia, Lei Fan, Ruinan Lu, et al.. (2012). Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia. Cancer Science. 103(5). 875–881. 40 indexed citations
15.
Zhu, Wei, Hua‐Guo Xu, Danxia Zhu, et al.. (2011). miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemotherapy and Pharmacology. 69(3). 723–731. 173 indexed citations
16.
Xu, Wei, Yinhua Wang, Lei Fan, et al.. (2011). Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia. Leukemia Research. 35(8). 1060–1065. 22 indexed citations
17.
Dong, Hua‐Jie, Cheng Fang, Lei Fan, et al.. (2011). TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage. Medical Oncology. 29(3). 2166–2173. 12 indexed citations
18.
Zhu, Yuandong, Li Wang, Chao Sun, et al.. (2011). Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia. Medical Oncology. 29(4). 2323–2331. 45 indexed citations
19.
Dong, Hua‐Jie, Fang Cheng, Lei Fan, et al.. (2011). MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL. International Journal of Cancer. 130(9). 2054–2061. 23 indexed citations
20.
Xu, Wei, Kourong Miao, Danxia Zhu, et al.. (2010). Enhancing the action of rituximab by adding fresh frozen plasma for the treatment of fludarabine refractory chronic lymphocytic leukemia. International Journal of Cancer. 128(9). 2192–2201. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoko Iehara Breakdown of academic impact, for papers by Katja Gwin Breakdown of academic impact, for papers by Navin Pinto Breakdown of academic impact, for papers by Jason Kaplan Breakdown of academic impact, for papers by Xiaochun Fei Breakdown of academic impact, for papers by Valentina Fonsato Breakdown of academic impact, for papers by Christoph Thorns Breakdown of academic impact, for papers by Yin‐Hsun Feng Breakdown of academic impact, for papers by Laura Boldrini Breakdown of academic impact, for papers by Deolinda Pereira
Rankless by CCL
2026